Infectious Complications in Biologic and Targeted Therapies, 1st Edition

Name: Infectious Complications in Biologic and Targeted Therapies, 1st Edition
SKU: 135455
Price: 6 USD
Availability: InStock

6 $

Format : Publisher PDF

File Size : 13.9 MB

Category: INFECTIOUS DISEASES BOOKS

Description

Infectious Complications in Biologic and Targeted Therapies, 1st Edition

By Carlos Cervera, Jose Maria Aguado
This book aims to approach the epidemiology, diagnosis and management of infectious complications related to the use of biologic and targeted therapies. The first part is a general overview on the epidemiology and prevention of infections with the use of these agents. Timelines, pre-treatment evaluation, use of vaccines and travel counseling. In the second part, we will analyze the specific risk of infections associated with the use of the most important agents. The third part approach the problem on a syndromic point of view. For example, how to evaluate pulmonary infiltrates in a patient receiving biologic agents. This part III includes the most difficult and conflicting syndromes that clinicians may face when evaluating these patients.This book is intended not only for infectious diseases specialists, but also for different medical specialties prescribing biologic and targeted therapies.

By Carlos Cervera and Jose Maria Aguado, the book “Infectious Complications of Biologic and Targeted Therapies” provides a comprehensive overview of the epidemiology, diagnosis, and management of infectious complications associated with the use of biologic and targeted therapies. This book is a valuable resource for infectious diseases specialists as well as medical professionals from various specialties who prescribe these therapies.

The first part of the book provides a general overview of the epidemiology and prevention of infections related to biologic and targeted therapies. It covers topics such as timelines for treatment, pre-treatment evaluation, the use of vaccines, and travel counseling. This section lays the foundation for understanding the specific risks and challenges associated with these therapies.

In the second part of the book, the authors delve into the specific risks of infections associated with the use of the most important biologic and targeted therapies. This section is particularly valuable for clinicians who need guidance on managing infections in patients receiving these therapies. The authors discuss the unique challenges posed by different agents and provide practical recommendations for diagnosis and management.

The third part of the book takes a syndromic approach to infectious complications. It focuses on evaluating and managing specific symptoms and syndromes that clinicians may encounter when dealing with patients on biologic and targeted therapies. For example, the authors address the evaluation of pulmonary infiltrates in these patients, which can be a complex and challenging scenario.

What sets this book apart is its relevance to a wide range of medical professionals. While it is a valuable resource for infectious diseases specialists, it is also highly beneficial for clinicians from other specialties who prescribe biologic and targeted therapies. The authors provide practical, evidence-based guidance that can help clinicians make informed decisions and provide optimal care to their patients.

The book is written in English and is published by Springer in the 1st edition (2022). It has a total of 483 pages, making it a comprehensive and detailed resource for clinicians. The ISBN-10 is 3031113624, and the ISBN-13 is 978-3031113628.

Why Order This Book?

Ordering “Infectious Complications of Biologic and Targeted Therapies” is a wise decision for healthcare professionals who are involved in the management of patients receiving these therapies. Here are a few reasons why:

Comprehensive Coverage: This book covers all aspects of infectious complications related to biologic and targeted therapies. It provides a complete understanding of the epidemiology, diagnosis, and management of these complications, making it a valuable reference for clinicians.
Multidisciplinary Approach: The book is designed to be relevant to various medical specialties. It caters not only to infectious diseases specialists but also to clinicians from other specialties who prescribe these therapies. It offers practical guidance that can be implemented in diverse clinical settings.
Author Expertise: The authors, Carlos Cervera and Jose Maria Aguado, are experienced and renowned experts in the field of infectious diseases. Their expertise shines through in the book, providing readers with reliable and up-to-date information.
Practical Recommendations: The authors provide practical recommendations based on the latest evidence and guidelines. The book offers clear and concise guidance on diagnosing and managing infectious complications, ensuring that clinicians can deliver the best possible care to their patients.
Timely and Relevant: With the increasing use of biologic and targeted therapies, the risk of infectious complications is a concern for healthcare professionals. This book addresses this crucial issue, helping clinicians stay updated and providing insights into the challenges they may face in their daily practice.

Ordering “Infectious Complications of Biologic and Targeted Therapies” will equip healthcare professionals with the knowledge and tools they need to assess, diagnose, and manage infectious complications related to these therapies. The comprehensive coverage, multidisciplinary approach, expert authorship, practical recommendations, and relevance of the book make it an indispensable resource in the field of infectious diseases.